Recent Articles from Investor Brand Network

Medical marijuana health insurance has long been viewed by cannabis businesses and patient advocates as a breakthrough that could reshape the industry. A recent proposed change to Medicare reimbursement regulations offered a brief spark of attention but delivered little for those hoping for broader coverage.

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

SuperCom (NASDAQ: SPCB), has been awarded a new electronic monitoring contract by a juvenile probation agency in Texas, marking the Company’s first engagement in the state and expanding its U.S. footprint to 14 states since mid-2024. The agency selected SuperCom to replace a long-time incumbent provider and will deploy the Company’s PureSecurity(TM) platform under a recurring revenue model. Leadership says the win underscores growing nationwide adoption of SuperCom’s next-generation monitoring technology and is expected to open additional opportunities as the Company builds on its momentum in new regions.

This article has been disseminated on behalf of Foremost Clean Energy Ltd. and may include paid advertising.

Electric cars are becoming more common in Europe, but the shift is still moving slower than many hoped. One area with huge potential to speed things up is company fleets. Businesses buy most of the new cars sold in Europe, which means their choices can strongly influence the market.

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

Disseminated on behalf of ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) and may include paid advertising.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

Disseminated on behalf of Silvercorp Metals Inc. (NYSE-A/TSX: SVM) and includes paid advertisement.

Uranium Energy (NYSE American: UEC) announced it will release its fiscal 2026 first quarter operating and financial results before markets open on Dec. 10, 2025.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.

Bitcoin and crypto-related shares extended their nearly two-month slide on Dec. 1, mirroring a broader retreat in tech shares that many investors argue have climbed too far, too fast.

HealthLynked (OTCQB: HLYK) announced the appointment of Duncan McGillivray, MBA, as Chief Operating Officer. McGillivray brings more than 30 years of leadership across healthcare, technology, capital markets, and project finance. He will oversee operational scale-up, support national payer and employer partnerships, and lead capital formation and banking relations as the company advances its planned Nasdaq Capital Market uplisting.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

When a late-stage clinical trial reports response rates nearly double what researchers expected, yet the stock market barely reacts, seasoned analysts take notice and wonder if investors are missing something significant. Soligenix (NASDAQ: SNGX), a New Jersey-based biopharmaceutical company focused on developing products to treat rare diseases where there is an unmet medical need, recently received updated analysis from Zacks Small-Cap Research following its announcement that milestone enrollment had been reached in the ongoing confirmatory Phase 3 FLASH2 trial of HyBryte(TM) for the treatment of cutaneous T-cell lymphoma, with the overall blinded response rate standing at 48% for patients who have completed treatment ( https://ibn.fm/Ol9Er ).

Copper prices registered another record as the week drew to a close after fresh orders for the metal flooding in from Japan and Taiwan caused a large wave of withdrawals from warehouses in a rush that was last witnessed on the London Metal Exchange back in 2013.

A new analysis is calling for major changes to how the United States screens for lung cancer. Current rules, the study argues, leave out most people who eventually develop the disease. Researchers behind the study say the system used today is far too narrow and fails to capture the full range of Americans who end up at risk.

Newton Golf Company (NASDAQ: NWTG), a performance-driven golf equipment innovator, is featured in the latest episode of IBN’s Stock2Me Podcast, where Executive Chairman and CEO Dr. Greg Campbell and CFO Jeff Clayborne discuss the company’s origins, physics-driven technology, and recent triple-digit Q3 growth. The conversation highlights Newton Golf’s Fast Motion Shaft, ongoing product innovation, and accelerating marketing momentum, with Campbell noting that improved ad performance is helping drive more than $4 in revenue for every dollar spent as the company scales its digital strategy.

This article has been disseminated on behalf of LaFleur Minerals Inc. and may include a paid advertisement.

Virginia is inching closer to clarifying how legal cannabis sales might work after years of political gridlock. A state panel created to review the issue is preparing to release a detailed proposal that could shape the future of the adult-use market.

The rapid transformation of the retail sector has made artificial intelligence (“AI”) one of the most important forces reshaping shopper behavior, and few companies are better positioned within this shift than A2Z Cust2Mate Solutions (NASDAQ: AZ ), an innovator in AI-powered smart-cart technology that enables seamless in-store checkout, personalized promotions and real-time data intelligence. A2Z provides retailers with an advanced platform that blends automation, shopper analytics and frictionless checkout to improve margins and enhance the customer experience.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently released a shareholder update following the debut of the company’s Solana treasury strategy ( https://ibn.fm/S14Up ).

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

This article has been disseminated on behalf of Carrier Connect Data Solutions Inc. and may include paid advertising.

Soligenix (NASDAQ: SNGX), announces its inclusion in a BioMedWire editorial examining the urgent rise of chronic and rare diseases in aging populations. With more than 30 million Americans living with rare disorders that often lack FDA-approved treatments, demand for novel therapies continues to grow. Soligenix is advancing late-stage programs including HyBryte(TM) for cutaneous T-cell lymphoma, now in its final confirmatory trial, positioning the Company at the intersection of scientific innovation and evolving national health-policy priorities focused on chronic and rare conditions.

Belite Bio (NASDAQ: BLTE) has priced an underwritten public offering of 2,272,727 American Depositary Shares at $154.00 per ADS, with a 30-day option for underwriters to purchase up to 340,909 additional ADSs. Gross proceeds are expected to total about $350 million before fees. The Company plans to use net proceeds for commercialization preparation, pipeline development, and general corporate purposes. Morgan Stanley & Co. LLC, Leerink Partners, BofA Securities and Cantor are serving as joint active book-running managers, with H.C. Wainwright & Co. as lead manager and Maxim Group LLC and Titan Partners Group as co-managers.

A new report shows that the price of platinum has surged by over 80% since this year began. This puts the metal on pace for its strongest annual performance since exchange trading started nearly four decades ago.

Xiaomi keeps smashing its own electric vehicle sales records as soaring demand pushes its EV business into new territory. The company has now logged its third month in a row with more than 40,000 deliveries, a run that signals how quickly its EV lineup has become a serious force in China’s auto market.

The fight against glioblastoma, a deadly brain cancer, has been boosted by new research conducted at Washington University that has developed nasal drops which can travel through nerves found in the nose and reach different parts of our central nervous system in order to fight the glioblastoma cells there.

Concerns about a potential AI bubble have stirred fresh unease on Wall Street, raising questions about whether the rapid buildup in AI spending can be sustained and what it means for the broader U.S. economy.

President Donald Trump’s decision to remove the renewable label from a major U.S. energy lab has set off another round of debate about the administration’s priorities and its long-running skepticism toward wind and solar projects. The shift was quietly posted on the lab’s website late Monday, confirming that the National Renewable Energy Laboratory in Colorado will now appear under a new banner, the National Laboratory of the Rockies .

The UK government is considering new rules that could block political parties from accepting donations made in crypto, a move that would directly affect Reform UK only months after it became the first party to take payments in crypto.

The Fear & Greed Index dropped to 9 in November, its lowest ever in the history of crypto. The expected “Updecember” surge in crypto didn’t happen and many are wondering whether there has been a change in trend or this is a mere market correction before the Bitcoin surge continues. Several experts shared their views on the subject and we capture what some of them had to say.

Lelantos Holdings (OTCID: LNTO) has engaged Aloba, Awomolo & Partners, a PCAOB-approved auditing firm, to complete its financial audits as the Company prepares an application to uplist its common stock to the OTCQB Venture Market. AAP will perform independent audits under PCAOB standards to support enhanced transparency, stronger internal controls, and alignment with OTCQB reporting requirements. Founded in 1981, the firm provides audit, tax, and financial advisory services with expertise in IFRS and PCAOB-standard external audits. Lelantos views the engagement as a key step toward improving liquidity, expanding its investor base, and increasing capital markets visibility.

This article has been disseminated on behalf of Powermax Minerals Inc. and may include paid advertising.

A new report from the Missouri Cannabis Trade Association says many retailers that advertise legal hemp products are instead selling cannabis products with high THC levels. The group’s findings come from laboratory tests on 55 products purchased at gas stations, smoke shops, and stores that market themselves as hemp or CBD sellers.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

As tech giants pour billions into traditional data center expansion, BluSky AI (OTC: BSAI) is uniquely positioned with its innovative Neocloud platform and modular SkyMod technology. “BluSky AI is focused to democratize access to enterprise-grade AI infrastructure through a fundamentally different approach, delivering compute power in months rather than years,” reads a recent article. “BluSky AI’s trajectory starts with its revolutionary Neocloud platform, built for AI from the ground up. BluSky AI’s initial Neocloud will consist of 150 MW with 20 planned locations spread across the U.S. With locations from 9 MW to 50 MW located closer to businesses to facilitate low latency-millisecond inferencing… The fabric supporting BluSky AI’s Neocloud will be the deployment of SkyMod modular data centers called ‘AI Factories.’ Each SkyMod is a proprietary unit prebuilt and tested in a controlled environment before being shipped for plug and play installation. The SkyMod One AI Factory supports 1 MW of compute capacity. Multiple SkyMods can be networked on a single location to support up to 60 MW and will be interconnected throughout the future defined 20 locations in the Neocloud platform.”

CNS Pharmaceuticals (NASDAQ: CNSP) was featured in a BioMedWire Podcast discussing its sharpened focus on glioblastoma multiforme (“GBM”), one of the deadliest and least treatable forms of cancer. In the interview, CEO John Climaco said of GBM, “Patients have very little hope. Our mission is to change that completely, and we think we have the drugs to do it.”

Beeline Holdings (NASDAQ: BLNE) was featured in a recent article that discussed its fast-growing digital mortgage platform and the company’s efforts to redefine the path to homeownership. The piece reads “Its AI-enabled proprietary platform can scale loan processing volumes rapidly while maintaining operational efficiency. By automating much of the underwriting and documentation process, Beeline can approve loans within minutes and close them in as few as 14 to 21 days, less than half the industry average. The platform’s design also caters to a changing borrower demographic. According to National Mortgage Professional, only 26.1% of Gen Z and 54.9% of Millennials owned homes in 2024, reflecting limited access to affordable mortgages. Beeline’s tools, including its AI decision engine and chatbot ‘Bob,’ aim to close that gap, giving buyers near-instant certainty about mortgage eligibility.”

Parler Technologies has initiated a Regulation D, Rule 506(c) private placement to raise up to $50 million, with the option to increase to $100 million, ahead of a planned Nasdaq or NYSE public offering targeted for late 2026 or early 2027. Managed by Digital Offering, the raise allows accredited investors to participate in Parler’s rebuilt, fully sovereign technology ecosystem, which includes Triton Cloud, Edgecast CDN, PlayTV, Kyvo, Cartix, and ParlerNews operating on an integrated blockchain protocol layer. The company says its independent infrastructure significantly reduces operating costs and enhances creator earnings while enabling a unified creator-commerce platform designed to support long-term growth and future public-market positioning.

Oncotelic Therapeutics (OTCQB: OTLC), reports that its 45% owned joint venture, Sapu Nano, has identified a High-RICTOR/Low-RPTOR molecular signature that predicts tumor sensitivity to Sapu003, the company’s intravenous Deciparticle(TM) formulation of everolimus. The biomarker framework, to be presented at the 2025 San Antonio Breast Cancer Symposium, is based on analysis of more than 9,000 tumor samples across 20 cancer types and represents the first prospective selection strategy for IV everolimus. Data show that mTORC2-dominant tumors — including HR+/HER2- breast, lung adenocarcinoma, gastric, renal, ovarian, AML and T-cell malignancies — exhibit heightened mTOR dependency and predicted sensitivity to Sapu003, which overcomes limitations of oral everolimus through higher tissue penetration, reduced GI accumulation and preserved metabolic specificity.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Disseminated on behalf of Silvercorp Metals Inc. (NYSE-A/TSX: SVM) and includes paid advertisement.

Disseminated on behalf of New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) and includes paid advertisement.

Disseminated on behalf of New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) and includes paid advertisement.

Artificial intelligence (“AI”) is accelerating across nearly every sector, reshaping how companies innovate, compete, and protect their digital assets. Datavault AI Inc. (NASDAQ: DVLT), a data-centric enterprise AI company, is working to ensure organizations of all sizes can deploy, secure and scale AI systems built on trustworthy data. The company’s platform helps transform fragmented, unstructured information into actionable digital assets, enabling businesses to implement AI more efficiently and responsibly.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that its Nu.Q® NETs H3.1 assay has been chosen as the sole biomarker for “DETECSEPS,” a French government-funded evaluation of early sepsis detection under the France 2030 plan. The program, led by the IHU SEPSIS and supported by a €6.3 million (~$7.3 million) grant, aims to transform emergency care for patients with infection and risk of sepsis progression.

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.

This article has been disseminated on behalf of Foremost Clean Energy Ltd. and may include paid advertising.

This article has been disseminated on behalf of Shelfie-Tech Ltd. and may include paid advertising.

This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

The start of this week saw the price of gold surge to a new high, bolstered by a weakening dollar and increasing expectations of rate cuts by the Fed. The precious metal’s price hit $4,241.27 an ounce, its highest level since October. Gold futures for February also rose to $4,274.80 an ounce.

Norway saw almost all new car registrations go electric in November. The country recorded 19,427 battery-only vehicles out of 19,899 newly registered passenger cars, pushing the EV share to 97.6 percent and producing one of the largest monthly registration totals the market has seen.

A newly published study shows that the fight against cancer could be boosted by considering approaches that seek to disrupt the mechanisms through which tumor cells respond to damage to their DNA. Targeting these pathways could make immunotherapy more effective for a lot more people.

AI has shifted from a side topic to a central theme in the biopharma world . Over the past year, multibillion-dollar AI collaborations have become routine, chipmakers have found new demand in drug research, and industry events have turned into forecasting sessions about how machine learning might reshape the lab.

Mitigating talent shortage challenges during an energy transition is a major issue for many firms . As renewable energy adoption accelerates, companies are finding it difficult to secure enough skilled professionals to keep up with demand. The rapid growth of solar, wind, and storage projects is outpacing the workforce, leaving a gap in both technical expertise and operational know-how. Without a solution, project timelines and sustainability goals are at risk.

eCommerce has changed quickly, and 2025 looks nothing like the early days when brands could pack orders from a small room and ship them out with little stress. Today, online shopping has higher demand, faster delivery standards, and far more competition. Because of this, many brands are rethinking how they manage the behind-the-scenes work that keeps orders moving. More companies are choosing to outsource their fulfillment operations, and this shift is becoming a core part of modern e-commerce strategy.

Massimo Group (NASDAQ: MAMO) has established Massimo AI Technology Inc., a wholly owned subsidiary created to advance the company into industrial and service robotics while supporting its long-term technology roadmap. The new division will develop practical automation and warehouse-assistance platforms, build a dedicated robotics supply and manufacturing foundation, and leverage Massimo’s existing strengths in electric systems and global operations. Leadership says the initiative broadens the company’s technology base, opens potential entry into high-growth automation sectors, and supports diversified long-term revenue opportunities.

BioMedWire Editorial Coverage : Chronic illnesses and rare disorders among older Americans represent a rapidly intensifying challenge for the U.S. healthcare system, with the National Institutes of Health estimating that more than 30 million people nationwide are living with a rare disease. Most of these conditions have no FDA-approved therapies, leaving older adults particularly at risk as age-related changes can mask or delay accurate diagnosis. This growing strain on care has heightened the need for novel treatments that address significant unmet medical needs. Soligenix Inc. (NASDAQ: SNGX) ( profile ), a late-stage biopharmaceutical developer, is advancing several rare-disease therapies, including HyBryte[TM] (synthetic hypericin) for cutaneous T-cell lymphoma (“CTCL”), where it is currently running the final confirmatory trial necessary before seeking global marketing authorization. As the Trump administration pursues new health-policy measures focused on chronic and rare diseases, Soligenix’s programs are positioned at a pivotal crossroads of scientific innovation and national healthcare goals. The company is working alongside several prominent leaders in the pharmaceutical and life sciences sectors, including AMGEN Inc. (NASDAQ: AMGN), Amicus Therapeutics Inc. (NASDAQ: FOLD), Citius Oncology Inc. (NASDAQ: CTOR) and…

A surge in hemp-derived THC products that reshaped convenience store shelves and fueled a fast-growing market appears to be heading toward a sharp slowdown. Tucked inside the bill that brought an end to the recent federal shutdown is a clause that would outlaw hemp-derived THC products nationwide.

Gloo (NASDAQ: GLOO), a technology platform serving the faith and flourishing ecosystem, priced its initial public offering of 9,100,000 shares of Class A common stock at $8 per share and granted underwriters a 30-day option to purchase up to 1,365,000 additional shares. Trading is expected to begin on the Nasdaq Global Select Market under the symbol GLOO, with the offering slated to close Nov. 20, 2025, subject to customary conditions. Roth Capital Partners is serving as sole book-running manager, with The Benchmark Company, Craig-Hallum Capital Group, Lake Street Capital Markets, Loop Capital Markets, and Texas Capital Securities acting as co-managers.

Safe Pro Group (NASDAQ: SPAI), a mission-driven provider of AI-powered defense and security solutions, is aligned with a major federal shift as the War Department moves to acquire roughly 300,000 low-cost drones under President Trump’s “Unleashing American Drone Dominance” initiative. The department’s new request for information outlines a $1 billion procurement program beginning in early 2026 that will fund four production “gauntlets,” starting with 12 vendors delivering 30,000 drones at $5,000 per unit and scaling toward 150,000 units at reduced costs. Secretary of War Pete Hegseth said the program aims to rebuild U.S. industrial capacity, integrate unmanned systems into all combat training, and ensure the military can field inexpensive battlefield drones at scale—tens of thousands in 2026 and hundreds of thousands by 2027.

Decent Holding (NASDAQ: DXST), an established wastewater treatment services provider in China, closed its $8 million registered offering consisting of 13,333,333 Class A ordinary shares at $0.60 per share and warrants to purchase 26,666,666 additional shares at 110 percent of the offering price with a 120-day term. Gross proceeds totaled $8 million before expenses, and the company plans to use the net proceeds to support business expansion, R&D, river-water quality management initiatives, wastewater treatment technology upgrades, and talent recruitment. The offering was conducted on a reasonable best-effort basis, with D. Boral Capital LLC serving as placement agent.

Oncotelic Therapeutics (OTCQB: OTLC), 45% owner of the Sapu Nano joint venture, announced new pharmacokinetic and tissue-distribution data showing that Sapu003, its intravenous Deciparticle (TM) formulation of everolimus, dramatically reduces gastrointestinal drug accumulation compared with oral everolimus. Oral dosing drives extreme gut exposure—up to 2,448× plasma levels in the stomach—while IV Sapu003 limits GI tissue levels to just 36–48× plasma, representing reductions of up to 67-fold. The company stated that this shift may improve tolerability, maintain the drug’s intrinsic metabolic profile, and provide more consistent systemic exposure.

From checkout lanes to connected carts, the retail experience is being reinvented — and A2Z Cust2Mate Solutions (NASDAQ: AZ ) is at the forefront of the movement. A2Z develops and deploys “smart-cart” technology that aims to transform how consumers shop in physical stores by melding convenience, personalization and data intelligence into the traditional grocery-store cart.

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company using artificial intelligence and genomics to transform oncology drug development, reported additional details and clinical insights from its completed Phase 1a dose-escalation study of LP-184 along with highlights from a recent webinar. The study in 63 heavily pre-treated patients with advanced solid tumors met all primary endpoints for safety and tolerability and established a clear recommended Phase 2 dose. Encouraging signals of durable disease control were observed, particularly in tumors with DNA damage repair pathway deficiencies. Building on these results, Lantern is advancing multiple biomarker-guided Phase 1b/2 trials across triple-negative breast cancer, glioblastoma multiforme, non-small cell lung cancer, and advanced urothelial carcinoma. The company and independent analysts estimate LP-184’s aggregate market opportunity could exceed $10 billion annually.

Safe & Green Holdings (NASDAQ: SGBX), a diversified holding company, said its energy subsidiary Olenox Corp. has received its U.S. Department of Transportation (“DOT”) number and is preparing to mobilize its service division assets. The approval marks a procedural but necessary step for the company as it restarts its oilfield services operations and expands service capacity across its portfolio of wells ( https://ibn.fm/Ncnk5 ).